Sorafenib tosylate
| Sorafenib tosylate | |
|---|---|
| Term | Sorafenib tosylate |
| Short definition | Sorafenib tosylate - (pronounced) (sor-A-feh-nib TOH-suh-layt) drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer) and thyroid cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Sorafenib tosylate - (pronounced) (sor-A-feh-nib TOH-suh-layt) drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer) and thyroid cancer. It is also being studied in the treatment of other types of cancer. Sorafenib tosylate blocks certain proteins that can help stop cancer cells from growing and dividing and kill them. It can also prevent the growth of new blood vessels that tumors need to grow. Sorafenib tosylate is a type of kinase inhibitor and a type of antiangiogenesis drug. Also called BAY 43-9006 and Nexavar
External links
- Medical encyclopedia article on Sorafenib tosylate
- Wikipedia's article - Sorafenib tosylate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski